Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test

Journal of Medical Virology

Volumn 81, Issue 12, 2009, Pages 2059-2065

  Papachristou, Eleni ^a   Sypsa, Vana ^a   Paraskevis, Dimitrios ^a   Gkekas, Athanasios ^b   Politi, Ekaterini ^b   Nicolaidou, Electra ^a   Anifantis, Ioannis ^c   Psichogiou, Mina ^c   Tsitsika, Artemis ^c   Hadjivassiliou, Maria ^a   Petrikkos, Georgios ^c   Katsambas, Andreas ^a   Creatsas, Georgios ^b   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

HPV genotyping; HPV prevalence; PCR

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; INFLAMMATION; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PAPANICOLAOU TEST; PREVALENCE; PROGNOSIS; SEXUAL BEHAVIOR; VIRUS DETECTION; VIRUS DIAGNOSIS; WART VIRUS;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; DNA, VIRAL; FEMALE; GREECE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RISK FACTORS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 70350589247     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21639     Document Type: Article

References (48)

1. Agorastos T, Bontis J, Lambropoulos AF, Constantinidis TC, Nasioutziki M, Tagou C, Katsouyiannopoulos V. 1995. Epidemiology of human papillomavirus infection in Greek asymptomatic women. Eur J Cancer Prev 4:159-167.
2. Arora R, Kumar A, Prusty K, Kailash U, Batra S, Das BC. 2005. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstetr Reprod Biol 121:104-109. (Pubitemid 40884647)
3. Bosch FX, Lorinez A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265. (Pubitemid 34293391)
4. Burk RD, Kelly P, Feldman J, Vermund SH, DeHovitz JA, Landesman SH. 1996a. Declining prevalence of cervicographical human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 23:333-341. (Pubitemid 26250669)
5. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. 1996b. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 174:679-689. (Pubitemid 26325881)
6. Chan SY, Delius H, Halpern AL, Bernard HU. 1995. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny and taxonomy. J Virol 69:3074-3083.
7. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003. Humanpapillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73. (Pubitemid 36241220)
8. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P. 1999. HPV testing in primary screening of older women. Br J Cancer 81:554-558. (Pubitemid 29458814)
9. Davies P, Kornegay J, Iftner T. 2001. Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol 15:677-700. (Pubitemid 33026194)
10. De Roda Husman AM, Walboomers JM, Hopman E, Bleker OP, Helmerhorst TH, Rozendaal L, Voorhorst FJ, Meijer CJ. 1995. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age-related pattern. J Med Virol 46:97-192.
11. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
12. Deacon JM, Evans CD, Yule R, Desai M, Taylor C, Peto J. 2000. Sexual behavior and smoking as determinants of cervical HPV infection and CIN3 among those infected: A case-control study nested within the Manchester cohort. Br J Cancer 83:1565-1572.
13. Evader M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G. 1995. Human papillomavirus infection is transient in young women: A population-based cohort study. J Infect Dis 171:1026-1030.
14. Evans FM, Adamson CS.-C, Papillo JL, St John TL, Leiman G, Cooper K. 2006. Distribution of human papillomavirus types in Thin-Prep Papanicolaou Tests according to the Bethesda 2001 terminology and correlationswith patient age and biopsy outcomes. Cancer 106:1054-1064. (Pubitemid 43297344)
15. Ferenczy A, Franco EL. 2002. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 3:11-16. (Pubitemid 34121141)
16. Ferlay J, Bray F, Pisani P, Parkin DM. 2005. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, version 2.0. IARC Cancer Base No.5 IARC Press, Lyon, France. [online]. http://www-depdb.iarc.fr/globocan/ GLOBOframe.htm.
17. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. 1996. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 174:1487-1493. (Pubitemid 26165265)
18. Fife KH, Katz BP, Brizendine EJ, Brown DR. 1999. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol 180:1110-1114.
19. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. 2000. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38:357-361. (Pubitemid 30043317)
20. Grce M, Husnjak K, Magdic' L, Zlacki M, Lucac J, Fistonic' I, Sikanic'-Dugic' N, Pavelic' K. 2001. Evaluation of genital human papillomavirus infections by polymerase chain reaction among Croatian women. Anticancer Res 21:579-584. (Pubitemid 32267575)
21. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME. 1994. Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235-240. (Pubitemid 24045578)
22. Hinchliffe SA, van Velzen D, Korporaal H, Kolk PL, Boon ME. 1995. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer 72:943-945.
23. Ho YFG, Bierman R, Beardsley L, Chang JC, Burk DR. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428. (Pubitemid 28135669)
24. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. 2000. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types. Int J Cancer 87:221-227. (Pubitemid 30434349)
25. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651. (Pubitemid 35340782)
26. Kroupis C, Thomopoulou G, Papathomas TG, Vourlidis N, Lazaris AC. 2007. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol Infect 135:943-950. (Pubitemid 47616475)
27. Meijer CJ, Snijders PJ, Castle PE. 2006. Clinical utility of HPV genotyping. Gynecol Oncol 103:12-17.
28. Mo LZ, Monnier-Benoit S, Kantelip B, Petitjean A Riethmuller D, Pretet JL, Mougin C. 2008. Comparison of AMPLICOR and hybrid capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: Use of INNO-LiPA genotyping assay to screen the discordant results. J Clin Virol 41:104-110. (Pubitemid 351187890)
29. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. 2001. Risks for incident human papillomavirus infection and low grade squamous intraepithelial lesion development in young females. JAMA 285:2995-3002. (Pubitemid 32550118)
30. Munoz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19:1-5. (Pubitemid 30847618)
31. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527. (Pubitemid 36159887)
32. Nobbenhuis MAE, Helmerhorst TJM, van den Brule AJC, Rozendaal L, Bezemer PD, Voorhorst FJ, Meijer CJLM. 2002. High-risk human papillomavirus clearance in pregnant women: Trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer 87:75-80. (Pubitemid 34888607)
33. Panotopoulou E, Tserkazoglou A, Kouvousi M, Tsiaousi I, Chatzieleftheriou G, Daskalopoulou D, Magiakos D. 2007. Prevalence of human papillomavirus types 6, 11, 16, 18, 31 and 33 in a cohort of Greek women. J Med Virol 79:1898-1905.
34. Parashari A, Singh V, Gupta MM, Satyanarayana L, Chattopadhya D, Sodhani P, Sehgal A. 1995. Significance of inflammatory cervical smears. APMIS 103:273-278.
35. Parkin DM, Pisani P, Ferlay J. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841. (Pubitemid 29108856)
36. Rosenfeld WD, Rose E, Vermund SH, Schreiber K, Burk RD. 1992. Follow-up evaluation of cervicographical human papillomavirus infection in adolescents. J Pediatr 121:307-311.
37. Sandri TM, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi MF, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M. 2006. Comparison of the digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 44:2141-2146. (Pubitemid 43902166)
38. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chang S, Lorincz A, Dalby DM, Janjusevic V, Keller JL. 2000. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. CMAJ 163:503-508. Available:www.cma.ca/cmaj/vol-163/issue-5/0503.htm. (Pubitemid 30742934)
39. Shlay JC, McGill WL, Masloboeva HA, Douglas JM Jr. 1998. Pap smear screening in an urban STD clinic. Sex Transm Dis 25:468-475.
40. Singh V, Gupta MM, Satyanarayana L, Parashari A, Sehgal A, Chattopadhya D, Sodhani P. 1995. Association between reproductive tract infections and cervical inflammatory epithelial changes. Sex Transm Dis 22:25-30.
41. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, Markowitz L, Unger ER. 2004. Epidemiology of human papillomavirus and abnormal cytologic test results in an urban adolescent population. J Infect Dis 189:46-50. (Pubitemid 38122328)
42. Vaccarella S, Hieu NT, Ferreccio C. 2008. IARC HPV Prevalence Surveys (IHPS) Study Group. Smoking and human papillomavirus infection: Pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 37:536-546.
43. 10-INNOLiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol 44:3122-3129.
44. Veress G, Csiky-Meszaros T, Konya J, Czegledy J, Gergely L. 1996. Follow-up of human papillomavirus (HPV) DNA and local anti-HPV antibodies in cytologically normal pregnant women. Med Microbiol Immunol 185:139-144. (Pubitemid 27007706)
45. Wallboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19. (Pubitemid 29406813)
46. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. 1999. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638.
47. Ward KA, Lowry BE, Houston JR, Maw RD. 1994. Cervical epithelial abnormalities in females with and without genital warts. Int J STD AIDS 5:380-381.
48. Zur Hausen H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.